PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
OCGN vs. NVAX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Performance

OCGN vs. NVAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ocugen, Inc. (OCGN) and Novavax, Inc. (NVAX). The values are adjusted to include any dividend payments, if applicable.

-60.00%-40.00%-20.00%0.00%20.00%40.00%JuneJulyAugustSeptemberOctoberNovember
-51.85%
-47.51%
OCGN
NVAX

Returns By Period

The year-to-date returns for both stocks are quite close, with OCGN having a 64.56% return and NVAX slightly lower at 61.77%.


OCGN

YTD

64.56%

1M

0.66%

6M

-50.72%

1Y

143.24%

5Y (annualized)

26.78%

10Y (annualized)

N/A

NVAX

YTD

61.77%

1M

-23.72%

6M

-47.50%

1Y

35.51%

5Y (annualized)

16.10%

10Y (annualized)

-22.76%

Fundamentals


OCGNNVAX
Market Cap$302.25M$1.35B
EPS-$0.17-$2.62
Total Revenue (TTM)$8.19M$800.68M
Gross Profit (TTM)$7.26M$566.95M
EBITDA (TTM)-$35.35M-$126.11M

Key characteristics


OCGNNVAX
Sharpe Ratio1.600.23
Sortino Ratio2.541.75
Omega Ratio1.281.21
Calmar Ratio1.610.34
Martin Ratio5.641.03
Ulcer Index28.60%32.08%
Daily Std Dev100.55%142.67%
Max Drawdown-99.97%-98.82%
Current Drawdown-99.87%-97.57%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Correlation

-0.50.00.51.00.2

The correlation between OCGN and NVAX is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Risk-Adjusted Performance

OCGN vs. NVAX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Ocugen, Inc. (OCGN) and Novavax, Inc. (NVAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for OCGN, currently valued at 1.60, compared to the broader market-4.00-2.000.002.004.001.600.23
The chart of Sortino ratio for OCGN, currently valued at 2.54, compared to the broader market-4.00-2.000.002.004.002.541.75
The chart of Omega ratio for OCGN, currently valued at 1.28, compared to the broader market0.501.001.502.001.281.21
The chart of Calmar ratio for OCGN, currently valued at 1.61, compared to the broader market0.002.004.006.001.610.34
The chart of Martin ratio for OCGN, currently valued at 5.64, compared to the broader market0.0010.0020.0030.005.641.03
OCGN
NVAX

The current OCGN Sharpe Ratio is 1.60, which is higher than the NVAX Sharpe Ratio of 0.23. The chart below compares the historical Sharpe Ratios of OCGN and NVAX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.00JuneJulyAugustSeptemberOctoberNovember
1.60
0.23
OCGN
NVAX

Dividends

OCGN vs. NVAX - Dividend Comparison

Neither OCGN nor NVAX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

OCGN vs. NVAX - Drawdown Comparison

The maximum OCGN drawdown since its inception was -99.97%, roughly equal to the maximum NVAX drawdown of -98.82%. Use the drawdown chart below to compare losses from any high point for OCGN and NVAX. For additional features, visit the drawdowns tool.


-100.00%-99.00%-98.00%-97.00%-96.00%-95.00%-94.00%-93.00%JuneJulyAugustSeptemberOctoberNovember
-99.87%
-97.57%
OCGN
NVAX

Volatility

OCGN vs. NVAX - Volatility Comparison

Ocugen, Inc. (OCGN) has a higher volatility of 23.96% compared to Novavax, Inc. (NVAX) at 17.20%. This indicates that OCGN's price experiences larger fluctuations and is considered to be riskier than NVAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


20.00%40.00%60.00%80.00%JuneJulyAugustSeptemberOctoberNovember
23.96%
17.20%
OCGN
NVAX

Financials

OCGN vs. NVAX - Financials Comparison

This section allows you to compare key financial metrics between Ocugen, Inc. and Novavax, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items